1.
Febriza A, Kasim VN. Potential effects of hydroxysafflor yellow A on reducing pulmonary inflammation and fibrosis due to SARS-COV2. J Biol Res [Internet]. 2022 Dec. 19 [cited 2024 Nov. 22];95(2). Available from: https://www.pagepressjournals.org/jbr/article/view/10572